Skip to main content
. 2015 Jul 24;10(7):e0133983. doi: 10.1371/journal.pone.0133983

Table 2. MCV coverage assessment of different age groups*.

Age range 0 dose 1 dose ≥2 doses
No. Percentage (95% CI) No. Percentage (95% CI) No. Percentage (95% CI)
8–17 months 22 19.6 (12.7–28.2) 62 55.4 (45.7–64.8) 28 25.0 (17.3–34.1)
18–23 months 2 3.5 (0.4–12.1) 20 35.1 (22.9–48.9) 35 61.4 (47.6–74)
≥24 months 7 1.9 (0.8–3.8) 25 6.7 (4.4–9.7) 341 91.4 (88.1–94.1)
sum 31 5.7 (3.9–8) 107 19.7 (16.5–23.3) 404 74.5 (70.7–78.2)

*The MCV doses include both routine immunization doses and SIA/SVA doses.